Surveillance or Focal Therapy

NAActive, not recruitingINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

December 1, 2026

Conditions

Prostate Cancer

Interventions

BEHAVIORAL

Explainer video

2 minute explainer video on treatment options

Trial Locations (1)

Kaiser Permanente, Los Angeles

All Listed Sponsors

lead

Kaiser Permanente

OTHER

NCT07207902 - Surveillance or Focal Therapy | Biotech Hunter | Biotech Hunter